Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Cantor Fitzgerald raises DeFi Development stock price target to $7 on treasury yield expansion

Published

on


Cantor Fitzgerald raises DeFi Development stock price target to $7 on treasury yield expansion

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Syrma SGS Technology shares jump 5% after JV pact with Japan’s Kaga Electronics

Published

on

Syrma SGS Technology shares jump 5% after JV pact with Japan’s Kaga Electronics
Shares of Syrma SGS Technology surged 4.84% to Rs 1,400.90 in Tuesday’s trading session after the electronics manufacturing services (EMS) company announced a strategic joint venture with Japan-based Kaga Electronics India Pvt. Ltd. to establish a state-of-the-art EMS manufacturing facility in India.

The partnership marks a significant step in Syrma’s efforts to strengthen its presence in the high-value electronics manufacturing segment while catering to the growing requirements of Japanese customers looking to expand their sourcing footprint in India.

According to the company’s regulatory filing, Syrma and Kaga signed an agreement to jointly establish, develop, and operate an advanced EMS manufacturing facility in India. The proposed venture will primarily focus on serving Japanese clients and leveraging the technical expertise and market reach of both partners.

Under the agreement, Syrma SGS Technology will hold up to a 60% stake in the proposed joint venture company (JVCo), while Kaga Electronics India will own up to 40%. Syrma plans to invest approximately Rs 15 crore in the venture, with Kaga contributing around Rs 10 crore. The transaction remains subject to customary regulatory approvals, conditions precedent, and closing requirements.

Advertisement

The governance structure of the JVCo will comprise a four-member board, with both partners nominating two directors each. The agreement also includes standard joint venture provisions such as rights of first refusal on share transfers, reserved matter protections, future funding mechanisms, rights issues, and capital structure safeguards.


Importantly, the company clarified that Kaga is not related to Syrma’s promoter or promoter group, and the transaction does not qualify as a related-party transaction.
Market participants viewed the collaboration positively, as it strengthens Syrma’s manufacturing capabilities and positions the company to benefit from increasing global supply-chain diversification and the growing trend of Japanese companies expanding production and sourcing operations in India.The announcement triggered buying interest in the counter, pushing Syrma SGS Technology shares nearly 5% higher during the session.

Share Price Performance

Syrma SGS Technology has delivered a strong rally over recent periods, gaining nearly 80% in the last three months and surging around 165% over the past year. The company currently commands a market capitalisation of approximately Rs 25,766 crore. During intraday trade today, the stock also touched a fresh 52-week high of Rs 1,410, reflecting strong bullish momentum.

From a technical standpoint, the stock appears stretched in the short term. The 14-day Relative Strength Index (RSI) stands at 76, a level typically considered overbought, suggesting the possibility of near-term consolidation or a pullback. However, the broader trend remains firmly positive, with the stock trading above all 8 key simple moving averages (SMAs), underscoring sustained bullish strength across timeframes.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Advertisement
Continue Reading

Business

Green light for $22m North Freo apartments

Published

on

Green light for $22m North Freo apartments

A multi-storey apartment block, estimated to cost $22 million, is set to be built next to a lot that was once owned by Victor Goh and is now selling to Edge Visionary Living.

Continue Reading

Business

Opinion: No mavericks on conference floor as need for speed agreed

Published

on

Opinion: No mavericks on conference floor as need for speed agreed

OPINION: There’s an urgent need to proceed with the Henderson and Western Trade Coast developments.

Continue Reading

Business

Empire Metals to host investor presentation on June 30

Published

on


Empire Metals to host investor presentation on June 30

Continue Reading

Business

Water Corp explores $1.3b Shenton Park call

Published

on

Water Corp explores $1.3b Shenton Park call

The Water Corporation is considering spending $1.3 billion to replace its ageing western suburbs water treatment plant, in a move which could free up prime land in Shenton Park.

Continue Reading

Business

Alpha and Omega Semiconductor: PC Headwinds May Delay Recovery Momentum (NASDAQ:AOSL)

Published

on

Alpha and Omega Semiconductor: PC Headwinds May Delay Recovery Momentum (NASDAQ:AOSL)

This article was written by

Brian Paradza, CFA, is building a new personal retirement portfolio from scratch for a 41-year-old and documenting the process transparently on Seeking Alpha under an independent research brand, The Stockalist. A dedicated financial analyst and blogger, Brian received the CFA Charter in 2019 and has spent nearly a decade producing investment commentaries and stock analysis reports for prominent financial platforms. He combines fundamental stock analysis with practical, long-term wealth accumulation for self-directed retail investors, explicitly accounting for cognitive and emotional biases in portfolio construction. The core investment philosophy driving this real-time portfolio project centers on building a resilient, all-weather retirement nest egg using a “Core-Satellite” approach. The strategy focuses primarily on North American equities across the U.S. and Canadian stock markets, with a specialized emphasis on three primary pillars: sustainable dividend growth stocks, premium Real Estate Investment Trusts (REITs), and diversifying broad-market ETFs (the core). Additionally, the portfolio selectively capitalizes on structural growth opportunities (satellite holdings) within the technology, materials, and financial sectors when valuations align with a psychologically acceptable margin of safety. Brian’s analytical framework prioritizes revenue growth opportunities, granular balance sheet health, free cash flow sustainability, and disciplined valuation metrics. Rather than chasing speculative hype, this project treats stock ownership as a true business partnership over a potential 20 to 25-year investment horizon. Readers and followers can expect diligent equity research, thorough breakdowns of corporate earnings reports, and unfiltered transparency regarding personal portfolio allocations and performance. The ultimate goal is to enjoy the wealth-building journey while collaborating with the Seeking Alpha community to perfect rigorous, data-driven analyses of income-generating assets and wealth compounders that accelerate capital growth. The Stockalist project helps provide the mental clarity needed to navigate market volatility while growing and preserving capital.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of INTC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Tension ‘likely’ in new Jersey government, says ex-chief minister

Published

on

Tension 'likely' in new Jersey government, says ex-chief minister

However, Moore, who was chief minister from July 2022 to 2024, when her government was brought down in a vote of no confidence, said she thought the challenge for Farnham this political term would be balancing ministers elected on wanting to cut costs and Senator Tom Binet who had previously called for more spending.

Continue Reading

Business

Three Things IREN Needs To Justify Its Valuation (NASDAQ:IREN)

Published

on

Three Things IREN Needs To Justify Its Valuation (NASDAQ:IREN)

This article was written by

I hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges behind drug development, which I now bring into my work as an investor and analyst. For the past five years, I have been active in the investing space, with the last four years dedicated to working as a biotech equity analyst alongside my lab work. My focus is on identifying promising biotechnology companies that are innovating in unique and differentiated ways, whether through novel mechanisms of action, first-in-class therapies, or platform technologies with the potential to reshape treatment paradigms. By combining my lab-based scientific expertise with financial and market analysis, I aim to deliver research that is both technically sound and investment-driven. On Seeking Alpha, I plan to write primarily about the biotech sector, covering companies at different stages of development, from early clinical pipelines to commercial-stage biotechs. My approach emphasizes evaluating the science behind drug candidates, the competitive landscape, clinical trial design, and the potential market opportunity, all while balancing financial fundamentals and valuation. My goal in publishing here is to share some insights that help investors better understand both the opportunities and of course the many risks in biotech. This is a sector where breakthrough science can translate into outsized returns, but also where careful scrutiny is essential. I look forward to contributing thoughtful analysis and engaging with readers who share an interest in this dynamic and rapidly evolving space.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

InfuSystem: A Good Time To Buy Before A Potential Breakout

Published

on

InfuSystem: A Good Time To Buy Before A Potential Breakout

InfuSystem: A Good Time To Buy Before A Potential Breakout

Continue Reading

Business

KPMG chairman, partners to exit scandal-tainted firm

Published

on

KPMG chairman, partners to exit scandal-tainted firm

The chairman of KPMG Australia is stepping down and two partners are leaving the firm after a bruising parliamentary hearing and allegations of wrongdoing at the major consultancy.

National chairman Martin Sheppard will leave the company shortly, along with audit partners Paul Rogers and Eileen Hoggett.

Mr Rogers and Ms Hoggett had been named in parliament for allegedly accessing confidential information from long-term audit client Lendlease with other KPMG staff to help them win additional contracts.

A whistleblower revealed the purported misconduct while also alleging mishandling of documents from Macquarie Group, Westpac, Dexus and Optus.

Advertisement

Several top KPMG staff including former chief executive Andrew Yates have already resigned over the scandal, which was the subject of a blockbuster hearing on Friday that included scorching criticism of the firm.

“The parliamentary committee’s inquiries highlighted issues, including unethical behaviour by senior personnel and the human impact of KPMG’s handling of the whistleblower,” said KPMG’s interim chief executive, Stan Stavros.

“KPMG Australia is focused on ensuring those failings are understood, addressed and not repeated.”

Mr Sheppard was hauled over the coals by senators at the committee hearing for his firm’s initial refusal to hand over internal documents, citing confidentiality, professional privilege and the risk of prejudicing the administration of justice.

Advertisement

Committee chair Deborah O’Neill described the move as an insult while flagging that KPMG could be investigated for contempt.

The consulting firm later relented and began producing material for the committee.

KPMG on Tuesday said it would overhaul its governance arrangements, including appointing its first independent chair and independent members to its Australian board.

Advertisement

The firm will also review and update the board’s role and remit, and appoint new independent board members in priority areas such as audit quality, ethics, whistleblower oversight and other matters of public interest.

An external third party will be appointed to undertake an immediate lessons-learned review into the whistleblower matter.

“The decisions announced today are necessary and immediate,” Mr Stavros said in a statement.

“We did not meet the standards expected of us and we recognise the impact this has had on the whistleblower, our people, our clients and the community.

Advertisement

“Trust will only be rebuilt through sustained action and demonstrable change. We are determined to confront what went wrong, act transparently and ensure these failings are not repeated.”
 

Advertisement
Continue Reading

Trending

Copyright © 2025